CINECA IRIS Institutional Research Information System

LUCCHI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.769
EU - Europa 5.296
AS - Asia 2.948
AF - Africa 232
SA - Sud America 138
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.468
IT - Italia 1.863
CN - Cina 1.531
DE - Germania 895
SE - Svezia 889
SG - Singapore 694
BG - Bulgaria 543
CA - Canada 293
TR - Turchia 262
UA - Ucraina 238
GB - Regno Unito 229
VN - Vietnam 211
FI - Finlandia 147
CI - Costa d'Avorio 140
RU - Federazione Russa 130
BR - Brasile 118
AT - Austria 106
IN - India 93
HK - Hong Kong 65
CH - Svizzera 62
FR - Francia 60
SN - Senegal 53
BE - Belgio 35
NL - Olanda 21
NG - Nigeria 20
IE - Irlanda 11
IR - Iran 11
EG - Egitto 9
PL - Polonia 9
ES - Italia 8
JO - Giordania 8
KR - Corea 8
RO - Romania 8
AU - Australia 7
BD - Bangladesh 7
CO - Colombia 7
CZ - Repubblica Ceca 7
DK - Danimarca 7
EU - Europa 7
MX - Messico 7
PK - Pakistan 7
ID - Indonesia 6
PT - Portogallo 6
RS - Serbia 6
JP - Giappone 5
SA - Arabia Saudita 5
LT - Lituania 4
MA - Marocco 4
NZ - Nuova Zelanda 4
AL - Albania 3
AR - Argentina 3
BJ - Benin 3
EC - Ecuador 3
GR - Grecia 3
IL - Israele 3
IQ - Iraq 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MY - Malesia 3
OM - Oman 3
TW - Taiwan 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
LU - Lussemburgo 2
PY - Paraguay 2
VE - Venezuela 2
AM - Armenia 1
BY - Bielorussia 1
CL - Cile 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
NA - Namibia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.402
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.558
Fairfield 1.448
Houston 1.108
Chandler 958
Santa Clara 923
Ann Arbor 813
Ashburn 728
Seattle 614
Sofia 542
Cambridge 532
Shanghai 508
Wilmington 497
New York 342
Singapore 336
Beijing 334
Milan 318
Boardman 279
Ottawa 275
Princeton 238
Jacksonville 228
Lawrence 221
Pisa 221
Florence 204
Medford 195
Serra 169
Izmir 167
Nanjing 157
Des Moines 147
Abidjan 140
Vicopisano 126
Vienna 102
Frankfurt am Main 92
San Diego 89
Dearborn 85
Istanbul 82
Bremen 67
Boulder 63
Nanchang 62
Bern 59
Hong Kong 59
Dong Ket 58
Ogden 56
Dakar 53
Kunming 46
Rome 43
Pune 39
Jüchen 38
Lancaster 36
Falls Church 35
Brussels 34
London 31
Los Angeles 31
Redwood City 29
Shenyang 28
Tianjin 28
Fuzhou 27
Jiaxing 24
Hebei 23
Lucca 23
Hefei 22
Pontedera 21
Cascina 20
Lagos 20
Norwalk 20
Changsha 19
Livorno 19
Turin 15
Auburn Hills 14
Guangzhou 14
Hangzhou 14
Phoenix 14
São Paulo 14
Dallas 13
Washington 13
Marseille 12
Munich 12
Nürnberg 12
Toronto 11
Jinan 10
Orange 10
Quanzhou 10
Wuhan 10
Dublin 9
New Delhi 9
Pistoia 9
Seacroft 9
Shenzhen 9
Helsinki 8
Naples 7
San Francisco 7
Warsaw 7
Chengdu 6
Chicago 6
Grafing 6
Indiana 6
Lappeenranta 6
Las Vegas 6
Verona 6
Zhengzhou 6
Bari 5
Totale 16.234
Salva come PNG Salva come JPEG
Nome #
null 346
Expression status of candidate genes in mesothelioma tissues and cell lines 247
La densità microvascolare (DMV) come marker prognostico e predittivo nelle neoplasie maligne dell'albero bronchiale in fase avanzata. 227
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 188
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 162
Surgical treatment of pleural recurrence from thymoma 161
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience 159
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis 155
Second primary lung cancer and relapse: treatment and follow-up. 149
Four thymus-related syndromes in a case of invasive thymoma 148
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 148
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 148
Percutaneous radiofrequency ablation (pRTA) of pulmonary tumors 146
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 143
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma 141
null 141
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma 139
null 138
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 138
TERMOABLAZIONE DI NEOPLASIE POLMONARI MALIGNE: QUALI PROSPETTIVE 137
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 137
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas 134
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis. 133
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 131
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 131
210P: Digital gene expression profiling to separate malignant pleural mesothelioma from benign reactive mesothelial hyperplasia 130
Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. 127
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 127
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma 126
Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development 124
null 123
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung 123
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 122
Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer. 121
[18F]FDG-PET/CT patterns of bone metastases in lung cancer 121
Surgical treatment of recurrent thymomas 121
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 120
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. 120
null 120
A gene-expression-based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations. 119
A strategy for thoracoscopic resection of small pulmonary nodules 119
Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment 119
Favourable survival outcome in patients with SCLC treated by sequential intensive chemotherapy and high dose chest irradiation 118
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 118
Accumulation of gene protein product P53 correlates with high microvessel count in non small cell lung carcinomas 117
Neoangiogenesis as prognostic indicator of survival in lung cancer. 117
Surgical treatment of non-small cell lung cancer in octogenarians 117
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 117
Gastropleural fistula as complication of post-pneumonectomy empyema 116
null 116
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. 116
The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis 116
null 114
Screen-detected multiple primary lung cancers in the ITALUNG trial 114
Surgical treatment of NSCLC in octuagenarians. 113
2ND PRIMARY LUNG-CANCER AND RELAPSE - TREATMENT AND FOLLOW-UP 112
Massive pneumoencephalus of late onset after an en-bloc resection for lung cancer 112
Reply to heyman and van schil 112
Polymer self-locking clips for vascular control during minimally invasive pulmonary lobectomies 112
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 112
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 111
WWOX expression in different histologic types and subtypes of non-small cell lung cancer 111
Is left upper lobectomy always worthwhile for early stage lung cancer? A comparison between left upper lobectomy, trisegmentectomy, and lingulectomy 111
Robotic lobectomy for lung cancer: Evolution in technique and technology 111
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 110
Pleural recurrence of thymoma: Surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy 109
Robotic extended thymectomy for early-stage thymomas 109
Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19 109
null 108
Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study 108
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 106
Chest wall resection for mesothelioma recurrence after surgery 106
Ten-year experience of mediastinal robotic surgery in a single referral centre 105
Nerve-Sparing Surgery in Advanced Stage Thymomas 105
Acute major airway injuries: clinical features and management 104
The multimodality treatment of thymic carcinoma 104
Radio-guided thoracoscopic surgery (RGTS) of small pulmonary nodules. 103
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 102
ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment 102
null 102
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 101
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 101
Recurrence and death in non small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count and gene protein products. 100
New Keywords in the Treatment of Malignant Pleural Mesothelioma 100
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 100
Gene-specific methylation analysis in thymomas of patients with myasthenia gravis 100
null 98
Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers 97
IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment 97
Angiogenesis as a prognostic indicator of survival in non small cell lung carcinoma: a prospective study. 96
Thymic carcinoma: a report of 13 cases 96
Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2) - Impact of adjuvant therapies in a subset of patients at high risk of recurrence 94
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 94
PTPN22 and myasthenia gravis: Replication in an Italian population and meta-analysis of literature data 92
Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis 92
Video robotic lobectomy 91
Gamma-probe guided thoracoscopic surgery of small pulmonary nodules 90
N2 lung cancer is not all the same: an analysis of different prognostic groups 89
Prognostic significance of tumoral angiogenesis in completely resected patients with late-stage lung cancer (Stage IIIa-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence. 88
Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results 88
Totale 12.218
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.696 0 0 0 0 0 0 418 316 366 253 268 75
2020/20211.686 147 89 115 70 230 81 101 161 172 125 115 280
2021/20222.660 23 170 97 130 487 371 139 124 165 149 132 673
2022/20233.053 369 375 229 289 307 413 42 219 549 11 221 29
2023/20242.234 199 193 236 269 306 394 120 79 41 40 117 240
2024/20252.979 153 301 74 464 821 758 408 0 0 0 0 0
Totale 21.843